Christoph I. Lee, MD, MS, MBA
Imaging is central to breast cancer screening, and the technology is constantly evolving. For example, in the last 15 years we’ve gone from using screen film mammography to digital and now 3-D mammography — and there are even more changes coming down the pipeline that can lead to improved screening and early detection of breast cancer. It’s exciting to be part of a field that’s progressing so quickly. What I also enjoy about this specialty is that I can use medical imaging to advocate for individual patients as well as large groups of people. One of my research programs amasses breast imaging data and outcomes from diverse populations so that we can provide better evidence to policymakers who set cancer screening guidelines.
I brought my father-in-law all the way from Montana to get treated at SCCA, and I’m grateful for the way his physicians cared for him. When you’re on the side of being the health advocate for your family member, you realize just how vulnerable people can feel during the diagnostic stage, when they’re waiting to find out whether they have cancer, how aggressive it is and how much disease is present. Having a caring, empathetic physician who understands the latest science and treatments but also takes the time to thoroughly answer questions is critical. I take pride in being a patient listener, fielding any concerns that come up and providing patients and families with concrete data they can use to make decisions.
I am a board-certified radiologist who specializes in using medical imaging to screen for, detect and manage breast cancer. My research is focused on emerging breast cancer screening technologies, health policy and population health outcomes. I have authored or co-authored more than 150 peer-reviewed journal articles and chapters about a variety of topics within radiology.
I also serve as the director of the Northwest Screening and Cancer Outcomes Research Enterprise (NW-SCORE), a partnership between UW Medicine and community radiology and pathology practices. The goal of NW-SCORE is to compile breast imaging data into a resource that can influence breast cancer screening practices and policies.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA's Christoph Lee, MD, discussed advancements in breast imaging with Cancer Network.
SCCA's Christoph Lee, MD, discussed imaging trends and innovations in breast imaging for breast cancer with Diagnostic Imaging.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.